Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPGI
4326
GPGI Inc
GPGI
$3.84B
| $619K | ﹤0.01% |
108,683
+82,508
| +315% | +$494K |
|
4327
Banco Santander Chile
BSAC
$16.6B
| $618K | ﹤0.01% |
32,774
+372
| +1% | +$6.93K |
|
|
FNCB
4328
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $617K | ﹤0.01% |
104,131
-32,730
| -24% | -$197K |
|
4329
Coastal Financial
CCB
$741M
| $616K | ﹤0.01% |
16,368
-2,861
| -15% | -$102K |
|
4330
Fortuna Silver Mines
FSM
$3.63B
| $615K | ﹤0.01% |
189,949
-193,757
| -50% | -$691K |
|
|
MAGN
4331
Magnera Corp
MAGN
$441M
| $614K | ﹤0.01% |
15,633
-77,293
| -83% | -$3.5M |
|
4332
CALL
Fastenal
FAST
$57.1B
| $613K | ﹤0.01% |
20,800
-27,800
| -57% | -$761K |
|
|
DBTX
4333
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $613K | ﹤0.01% |
159,224
-87,093
| -35% | -$320K |
|
4334
AdaptHealth
AHCO
$772M
| $613K | ﹤0.01% |
50,352
-355,146
| -88% | -$3.96M |
|
4335
CI&T Inc
CINT
$439M
| $612K | ﹤0.01% |
97,676
-58,444
| -37% | -$282K |
|
4336
Heritage Insurance Holdings
HRTG
$1.01B
| $610K | ﹤0.01% |
158,563
-197,750
| -55% | -$793K |
|
4337
Orange County Bancorp
OBT
$511M
| $610K | ﹤0.01% |
32,956
-58,124
| -64% | -$1.03M |
|
4338
Distribution Solutions Group
DSGR
$1.61B
| $608K | ﹤0.01% |
+23,352
| New | +$549K |
|
|
AXNX
4339
PUT
DELISTED
Axonics, Inc. Common Stock
AXNX
| $606K | ﹤0.01% |
12,000
+2,000
| +20% | +$106K |
|
4340
PUT
Assurant
AIZ
$14.1B
| $603K | ﹤0.01% |
+4,800
| New | +$598K |
|
|
ADAP
4341
DELISTED
Adaptimmune Therapeutics
ADAP
| $603K | ﹤0.01% |
651,962
+352,370
| +118% | +$420K |
|
|
NVTA
4342
DELISTED
Invitae Corporation
NVTA
| $601K | ﹤0.01% |
531,984
+381,212
| +253% | +$481K |
|
4343
CALL
Krystal Biotech
KRYS
$10.4B
| $599K | ﹤0.01% |
+5,100
| New | +$521K |
|
|
LLAP
4344
DELISTED
Terran Orbital Corporation
LLAP
| $599K | ﹤0.01% |
399,122
-986,012
| -71% | -$1.56M |
|
4345
Peoples Bancorp of North Carolina
PEBK
$233M
| $598K | ﹤0.01% |
32,823
+8,372
| +34% | +$191K |
|
4346
iShares Core S&P US Value ETF
IUSV
$28B
| $597K | ﹤0.01% |
+7,634
| New | +$570K |
|
4347
PUT
STMicroelectronics
STM
$44B
| $595K | ﹤0.01% |
+11,900
| New | +$552K |
|
4348
CALL
AngloGold Ashanti
AU
$57.2B
| $595K | ﹤0.01% |
28,200
-641,800
| -96% | -$16.2M |
|
|
4349
PUT
AngloGold Ashanti
AU
$57.2B
| $595K | ﹤0.01% |
28,200
-161,700
| -85% | -$4.08M |
|
4350
Peapack-Gladstone Financial
PGC
$800M
| $594K | ﹤0.01% |
21,919
-73,665
| -77% | -$2.01M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.